The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury

Michael R. Hoane, Jeremy L. Pierce, Michael A. Holland, Nicholas D. Birky, Tan Dang, Michael P. Vitek, Suzanne E. McKenna

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

It has previously been shown that small peptide molecules derived from the apolipoprotein E (ApoE) receptor binding region are anti-inflammatory in nature and can improve outcome following head injury. The present study evaluated the preclinical efficacy of COG1410, a small molecule ApoE-mimetic peptide (1410 daltons), following cortical contusion injury (CCI). Animals were prepared with a unilateral CCI of the sensorimotor cortex (SMC) or sham procedure. Thirty mins post-CCI the animals received i.v. infusions of 0.8 mg/kg COG1410, 0.4 mg/kg COG1410, or vehicle. Starting on day 2, the animals were tested on a battery of behavioral measures to assess sensorimotor (vibrissae-forelimb placing and forelimb use-asymmetry), and motor (tapered balance beam) performance. Administration of the 0.8 mg/kg dose of COG1410 significantly improved recovery on the vibrissae-forelimb and limb asymmetry tests. However, no facilitation was observed on the tapered beam. The low dose (0.4 mg/kg) of COG1410 did not show any significant differences compared to vehicle. Lesion analysis revealed that the 0.8 mg/kg dose of COG1410 significantly reduced the size of the injury cavity compared to the 0.4 mg/kg dose and vehicle. The 0.8 mg/kg dose also reduced the number of glial fibrillary acid protein (GFAP+) reactive cells in the injured cortex. These results suggest that a single dose of COG1410 facilitates behavioral recovery and provides neuroprotection in a dose and task-dependent manner. Thus, the continued clinical development of ApoE based therapeutics is warranted and could represent a novel strategy for the treatment of traumatic brain injuries.

Original languageEnglish (US)
Pages (from-to)1108-1118
Number of pages11
JournalJournal of Neurotrauma
Volume24
Issue number7
DOIs
StatePublished - Jul 2007
Externally publishedYes

Keywords

  • ApoE
  • Behavioral recovery
  • GFAP
  • Neuroprotection
  • Recovery of function
  • TBI
  • Trauma

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury'. Together they form a unique fingerprint.

Cite this